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Psychometric Properties of the Arabic Version of the Functional 
Assessment of Chronic Illnesses Therapy-Fatigue (FACIT-F) in 
Arabic Cancer Patients 
Abstract:  
Background:  The Functional Assessment of Chronic Illness Therapy (FACIT) is a measurement 
system that was developed to assess the health-related quality of life among patients with cancer 
and other chronic illnesses. The Functional Assessment of Chronic Illness Therapy- Fatigue 
(FACIT-F) is a 40-item questionnaire, and it is the one of most frequently used instrument to assess 
fatigue in cancer populations. The aim of the study is to evaluate the psychometric properties of 
the Arabic FACIT-F among patients diagnosed with cancer.  
Methods: Following a translated and cross-cultural evaluation procedure, of the FACIT-F Arabic 
version. A cross-sectional and descriptive correlational design was conducted. A total of 369 
patients with cancer completed the FACIT-F, which consists of the Functional Assessment of 
Cancer Therapy – general scale’s (FACT-G) 27-items, and the 13-item Functional Assessment of 
Chronic Illness Therapy-Fatigue (FACIT-Fatigue). The scale was assessed in terms of 
acceptability, internal consistency and validity. Construct validity was explored through 
confirmatory factor analysis.  
Results: The FACT-G had acceptable fit in the four factor model, whereas the FACIT-Fatigue 
was found to be acceptable for the one-factor model in Arabic patients diagnosed with cancer. The 
Cronbach’s alpha coefficient for the Arabic FACIT-Fatigue was 0.92, whereas the total score for 
FACT-G was 0.92, which showed good reliability. There was evidence that discriminate validity 
analysis was generally very good for the FACIT-Fatigue and FACT-G Arabic versions.  
Conclusion: The Arabic versions of the FACIT-Fatigue and FACT-G demonstrated good 
reliability and validity for assessing fatigue and quality of life in patients diagnosed with cancer. 
 





The diagnosis of cancer is a major life stressor that can affect the physiological, psychological and 
physical state of the individual. Cancer Related Fatigue (CRF) prevalence ranges between 50% 
and 90%.1 The majority of patients with cancer report fatigue as the most distressing symptom 
affecting their quality of life (QoL). 2,3 
Several instruments have been developed to measure CRF in English; one of the most widely used 
and validated is the Functional Assessment of Chronic Illnesses Therapy-F (FACIT-F). 4,5 This 
questionnaire consists of QoL questions and an additional scale for measuring fatigue. 6 The QoL 
is known as the Functional Assessment of Cancer Therapy – General (FACT-G). The FACT-G 
has four subscales: seven items for physical well-being (PWB); seven items for social/family well-
being (SWB); six items for emotional well-being (EWB); and seven items for functional well-
being (FWB). 7 The additional scale for measuring fatigue, containing 13 items, is known as the 
Functional Assessment of Chronic Illnesses Therapy – Fatigue (FACIT-Fatigue), and can be used 
as a stand-alone brief assessment of fatigue. Therefore, FACIT-F refers to the 40-item 
questionnaire with all five subscales (physical, social/family, emotional functional, well-being and 
fatigue); FACT-G relates only to the four QoL subscales; and FACIT-Fatigue relates only to the 
13-item fatigue scale. 
FACIT-F 40-items has been validated for use with a variety of cancer diagnoses and treatments; 
the original scale showed strong internal consistency (coefficient alpha 0.93-0.95) and good 
stability (test-retest,  r =0.87). 6 Other studies using the instrument have translated it into Spanish, 
8 French and Dutch 9, Japanese,10 Persian,11 and Portuguese. 12,13 The internal consistency in the 
translated versions ranged from 0.79 to 0.94. 
A lack of appropriate scales to measure CRF is one of the challenges to identifying fatigue 
symptom disorders among patients with cancer in Arabic populations. Twenty-seven countries in 
the Middle East and North Africa have Arabic as the official language, and it is the 6th most spoken 
language in the world. 14 However, the FACIT-F 40-items has not been validated in clinical 
samples in Arabic speaking countries.  
 
 
Therefore, the aim of this study was to examine the validity and reliability of the Arabic FACIT-
F 40-items, version 4, in a heterogeneous sample of cancer patients in Oman. Validation of the 
Arabic FACIT-F 40-items in an Arabic country will provide a suitable and acceptable cultural fit 
instrument for screening and assessing fatigue in clinical practice. 
Methods: 
Participants:  
A cross-sectional survey (November 2018 and January 2019) was used with participants recruited 
from the National Oncology Centre outpatients’ clinic in Oman. The inclusion criteria were: ability 
to speak and write in Arabic, patients over 18 years of age, no known psychiatric or neurological 
disorders, diagnoses of any type of cancer, completed surgical intervention, chemotherapy or/and 
radiotherapy treatment at least one month prior to recruitment. 
The sample size was determined as 10 participants required  per item.15,16 For FACIT-Fatigue (13 
items) 130 and FACT-G (27 items) 270 participants were required. Given the expectation of a non-
responders, a sample size of 400 participants was chosen. 
Ethical permission was sought and granted by Research and Ethical Review and Approval 
Committee in the Directorate General of Planning and Studies at the Ministry of Health, Oman. 
Participants gave informed consent prior to completion of the survey.  
Instruments:  
Demographic information collected included age, gender, educational level, marital status, 
employment status, type of cancer, stage, type of treatment finished and time since diagnosis. 
Fatigue was measured using the FACIT-F. 6 Responses were scored on a 5-point scale which 
ranged from 0 to 4. 
The FACIT-Fatigue 13 items provided scores that ranged from 0 to 52. Higher scores indicated no 
fatigue and the lowest score, the worst possible fatigue. The FACT-G was used to measure QoL, 
with the total score calculated by summing the 4 subscales. Possible scores ranged from 0 to 108, 
with higher scores indicative of a good level of QoL. Permission was given by the developers to 
use the Arabic version of the FACIT-F instrument. 
 
 
Translation of FACIT-F:  
An Arabic version of the FACIT-F 40-items was available on the FACIT website 
(http://www.facit.org/TransHome)17 and translated using the method described by Bonomi et al. 
18 However, the FACIT team recommend cross-language and cross-cultural evaluation to test the 
instrument. 19 
To ensure the applicability of the instrument for the current study population, the FACIT-F 40-
items Arabic version was compared with the original English version by two independent bilingual 
translators. This ensured that the scales were translated into the Modern Standard Arabic language 
that is used for official purposes in all Arabic countries. The final version was compared with the 
original Arabic version proposed by the FACIT Group; it was evaluated by a team of three Arabic 
language experts, two translators and two oncology experts. To examine any difficulties in items 
comprehension of the FACIT-F, the scales were piloted with ten patients diagnosed with cancer. 
No changes for any words or phrases of the Arabic FACIT-F translation presented by the FACIT 
groups were necessary. [Online Supplement 1: FACIT-Fatigue 13-Items Arabic Version; Online 
Supplement 2: FACT-G 27-Items Arabic Version]. 
Statistical Analyses: 
The 27-item FACT-G and 13-item FACIT-Fatigue were analysed separately. 
Construct validity of the FACT-G 27-items and FACT-F 13-items were examined using two 
separate Confirmatory Factor Analysis (CFA) conducted using AMOS 25 to test the hypothesis 
that the FACIT-Fatigue was unidimensional and the items in the FACT-G were best represented 
by a four-factor model. The following criteria were set to define acceptable model fit: Root Mean 
Square Error of Approximation (RMSEA) of less than or equal to 0.08; Comparative Fit Index 
(CFI) greater than 0.90; and Tucker-Lewis index (TLI) greater than 0.90. 16 20 Montan et al. 21 
previously used these model fit indices to examine the structure of the FACIT- Fatigue and FACT-
G. 
The internal consistency of the two scales were evaluated using Cronbach’s alpha coefficient for 
each of the subscales and the overall scales. Cronbach coefficient of 0.70 or higher was considered 
acceptable. 22 The floor and ceiling effects were reported if more than 15% of the respondents 
achieved the lowest or highest possible scores 23.22 
 
 
Discriminant validity of the FACT-G and FACIT-Fatigue, determined by independent t-test and 
analysis of variance (ANOVA), is the ability of the scale to differentiate defined groups according 
to patient demographic and clinical characteristics. Statistical analyses were performed using the 
Statistical Package for the Social Sciences (SPSS) version 25.0. Significant levels of less than 0.05 
were chosen, and all p were two-sided. 
Results: 
Four hundred patients were eligible to participate; of these, 369 (92%) returned valid 
questionnaires. Eleven refused participation, seven submitted incomplete questionnaires, and 
thirteen did not return the questionnaire. 
The majority of the participants were female 66.4% (n=245). 28% had completed a secondary 
level education, 27.4% (n=101) held a degree (college or higher); 20% of the participants had no-
formal education but they were able to read and write in Arabic (Table 1). 
Psychometric Properties  
Confirmatory Factor Analysis 
The FACT-G had 34% respondents did not answer GS7, due to participants exercising the option 
to skip GS7 (I am satisfied with my sex life). Factor analysis is sensitive to missing values and 
given that data were not missing randomly, imputation methods were deemed inappropriate. 
Hence, GS7 was removed from further CFA results for the 26-item FACT-G. This indicated that 
a four factor model was not an adequate fit for the data (λ = 0.22 to 0.85; χ2/df = 2.79, CFI= 0.88; 
RMSEA= 0.07; TLI = 0.87). Factor loadings for item GE2 (I am satisfied with how I am coping 
with my illness) were low (λ= 0.22); this item was removed from the second order factor model, 
which revealed a better fit (λ = 0.44 to 0.88; χ2/df = 2.729, CFI= 0.90; RMSEA= 0.07; TLI = 0.90). 
A correlated error was apparent between items GF1 (I am able to work (including work at home)) 
and GF2 (My work (including work at home) is fulfilling); this resulted in an acceptable model fit 
(λ = 0.44 to 0.88; χ2/df = 2.448, CFI= 0.92; RMSEA= 0.06; TLI = 0.91), (Figure 1). 
 A one-factor model24 was tested for the FACIT-Fatigue. Loadings for the 13 items ranged from λ 
= 0.37 to 0.89, showing a less than optimal fit for the data (CFI= 0.84; RMSEA= 0.15; TLI = 0.81). 
 
 
Modification indices were examined and six items were found to have significant shared error 
variance: An3 (I have trouble starting things because I am tired); An4 (I have trouble finishing 
things because I am tired); An5 (I have energy); An7 (I am able to do my usual activities); An15 
(I am frustrated by being too tired to do the things I want to do) and An16 (I have to limit my social 
activity because I am tired). Items An3, An4, An15 and An16 had similar content. Items An5 and 
An7 were the only items in the FACIT-Fatigue -13 that were positively phrased, the other items 
were negatively constructed. The refined model fit indices of the sample were CFI= 0.93; 
RMSEA= 0.10; TLI = 0.91, (Figure 2). 
Reliability: 
Internal consistency for the FACT-G 27-item scale was 0.92. Subscale values were 0.91 for PWB; 
0.71 for SWB; 0.81 for EWB; and 0.87 for FWB. Internal consistency for the FACT-G 25-item 
scale (after removal of GS7 and GE2) was 0.92. Subscale values were 0.92 for PWB; 0.73 for 
SWB-6; 0.84 for EWB-5; and 0.87 for FWB. 
The alpha coefficient of the fatigue scale for the FACIT-Fatigue 13-items Arabic version was 0.94. 
These findings indicated acceptable/excellent internal consistency for all subscales and aggregated 
scores, which compares favourably with those of the original English instrument. Ceiling and floor 
effect for scales and subscales were less than 15%, other than SWB ceiling effect (17.6%), due to 
the deleted item, GS7 (Table 2). 
Discriminant Validity:  
The mean scores of the FACIT-Fatigue, and the FACT-G and subscales showed discriminant 
validity between different patients’ groups according to age, cancer site, stage of disease and 
comorbidities (Table 3). Fatigue scores were highest among patients with lung cancer compared 
to patients with other cancers. Cancer site was associated with significant differences in physical, 
emotional and functional well-being and total FACT-G score (p<0.05). The mean score of the 
FACIT-Fatigue scale and FACT-G physical, social/family, emotional and functional well-being 





To our knowledge, this is the first psychometric study of the FACIT-Fatigue scale that has 
specifically been examined in an Arabic cancer population. The present study has shown that the 
FACT-G and FACIT-Fatigue scales reached acceptable levels of reliability and construct validity. 
The internal consistency reliability of the Arabic version of the FACIT-Fatigue was α=0.94, which 
was higher than the original study of Yellen et al. 6 (α=0.93). The internal consistency of the 
FACIT-Fatigue in Spanish  was 0.88 8, in Brazilian it was 0.79 13, among patients diagnosed with 
almost similar cancers. The FACT-G subscales, PWB, SWB-6, EWB-5 and FWB, also had good 
reliability estimates (0.73 to 0.92) with total internal consistency of α=0.92; this is in comparison 
with the result of the original version, which was α=0.89.  
Further, most of the FACIT-Fatigue and FACT-G scales and subscales did not have floor or ceiling 
effects: only SWB-6 presented with 17.5%, and this may because of the removal of GS7. 
Therefore, items’ analyses supports the content validity of the scale. 23 
Both the FACIT-Fatigue and FACT-G showed good to excellent evidence of construct validity; 
both scales appeared to be capable of discriminating between groups that differed in prognosis. 
The result of this study supports the discriminant validity of both scales. Previous research has 
established the discriminant validity of the FACT-G 24 and the FACIT-Fatigue 6, and has shown 
similar results in the original validation. Moreover, the finding of the discriminant validity of the 
Arabic version is consistent with Persian 11 and English versions. 25 
Confirmatory factor analysis was conducted for the FACT-G and FACIT-Fatigue for all 
participants. The FACT-G had the highest rate of missing data; this was due to 125 (33.9%) 
participants not answering GS7. In Arabic culture, sex is considered a private issue that cannot be 
discussed. 26 This may explain the reluctance of participants to complete this item within the 
questionnaire. This is similar in different populations; for example Korean 27 Chinese 28 Spanish 
29 and Western European 18, however, all those studies recommended to keep the GS7 item.   
Item GE2 (I am satisfied with how I am coping with my illness) presented a problem with regards 
to the psychometric sensitivity as the item (λ =0.22), had a low factor loading. This may be 
explained as cross-culturally problematic, as the word ‘coping’ translated into Arabic terms is 
‘Takuble’. In Islamic culture, Muslims’ religious beliefs dictate that the disease or illness is God’s 
 
 
will 30; consequently, Muslims should cope with illness without regard to satisfaction. Another 
possible explanation was that GE2 is the only positively worded item among five items which 
were negatively worded. Previous studies have reported similar issues in Spanish 29 and English 25 
version of FACT-G regarding the loading of GE2. This item may contribute to measurement 
error,16 and lead to a low factor loading.   
In the final model, the correlation of items GF1 (I am able to work (including work at home)) and 
GF2 (My work (including work at home) is fulfilling) may be due to the similarity of items’ 
content. A similar correlation was found between items GF1 and GF2 in the CFA conducted on 
cancer patients in Brazil. 31 Although two items GE2 and GS7 were problematic to CFA, it 
recommended to keep the structure of FACT-G 27-items Arabic version the same as the original 
publication;  also recommended by Dapueto et al. 32, Lee et al.27 and  Smith et al.33  
The CFA of FACIT-Fatigue has been proposed as a unidimensional scale with the range of factor 
loadings being acceptable (0.39 to 0.89). The possible explanation for a high correlation between 
six items was that the participants had given similar answers: 59% for An3 and An4, 48% for An5 
and An7, and 60% for An15 and An16. This may indicate that these items have similar content. 
Another possible reason for correlation between these items is due to the translation. In the 
English-Arabic comparison, for item An5 (I have energy), ‘energy’ is translated into Arabic as 
‘Alhayawia’; furthermore, in item An15, ‘I am frustrated’ was translated into Arabic as ‘Asheur 
Bialaihbat’. These two words were translated into Modern Arabic and may have been 
misinterpreted by the participants. In this study, 44.4% of the participants had basic education or 
less; these participants may have had difficulty understanding these items. 
In this study, CFA confirmed the one factor structure of FACIT-Fatigue. Cella et al. 34, Coroiu et 
al. 35 and  Montan et al. 21 all showed that the 13-item FACIT-Fatigue scale has acceptable fit in 
the unidimensional model.  This study found that RMSEA = 0.10, which is below the set criterion 
(RMSEA=0.8) for an acceptable CFA model fit, however a similar result was reported by Cella et 
al. 34 and  Montan et al. 21 It is recommended that the structure is kept and the contact instrument 




A think loud study would be recommended for FACIT-Fatigue and FACT-G Arabic versions in 
which the participant describes their thinking as they answer each items of the scales.36 This, 
method can provide content validity 37 and response processes 38 to each item of FACIT-Fatigue 
and FACT-G Arabic scales.  
The current study has some limitations. The stability of the instrument was not reported using test-
retest reliability; therefore, further assessment of test-retest reliability is needed.  
Conclusion:  
This is the first study to validate the FACIT-F in a clinical sample in an Arabic speaking country. 
The Arabic versions of the FACIT-Fatigue and FACT-G, version four, have acceptable 
psychometric properties of internal consistency and discriminant validity. Therefore, the Arabic 
version of FACIT-F is a reliable and validated instrument to assess fatigue and QoL and can assess 
CRF in Arabic cancer populations. Further research on the Arabic versions should evaluate test-
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Figure 1: Factors structure of the Functional Assessment of Cancer Therapy-General 25-items 
λ = .44 to .88; ꭓ2/df = 2.448, Comparative Fit Index (CFI)=.92; Root mean Square Error of 








Figure 2: Model 2 Functional Assessment of Cancer Therapy-Fatigue 13-items with 
Correlation, λ = .40 to .89; ꭓ2/df = 5.106; Comparative Fit Index (CFI)=.93; Root mean Square 
Error of Approximation (RMSEA)= .10; Tucker-Lewis Index (TLI) = .91 
 
 
Table 1: Demographic and Clinical Characteristic of Participants (N=369):   
 
 
 Demographic Characteristic  Clinical Characteristic 
  n %   n % 
Gender    Cancer Site   
Male 124 33.6  Breast 139 37.7 
Female 245 66.4  Colorectal 54 14.6 
Age    Stomach 18 4.9 
18-30 36 9.8  Others 29 7.9 
31-40 84 22.8  Lung 20 5.4 
41-50 95 25.7  Gastrointestinal 19 5.1 
51-60 76 20.6  Brain 19 5.1 
More than 60 78 21.1  lymphoma 20 5.4 
Marital Status    Gynaecological 24 6.5 
Married 273 74  Urinary 27 7.3 
Single 40 10.8  Stage   
Divorced/ Separated 
/widowed 56 15.2  Ⅰ 34 9.2 
Education Level    Ⅱ 145 39.3 
Non-Formal Education 75 20.3  Ⅲ 107 29 
Basic Education 89 24.1  Ⅳ 72 19.5 
Secondary Education 104 28.2  Unspecified 11 3 
Degree 101 27.4  Month Since Diagnosis   
Employment Stats    < 12 months 157 42.5 
Employed 125 33.9  12-24 months 127 34.4 
Retired 71 19.2  25-36 months 52 14.1 
Unemployed 173 46.9  > 36 months 33 8.9 
   
 Type of Treatment 
Finished   
    Chemo and Radio 234 63.4 
    Chemotherapy 122 33.1 
    Radiotherapy 13 3.5 
    Comorbidities   
    None 193 52.3 
    Asthma 8 2.2 
    Anaemia 13 3.5 
    Diabetes 21 5.7 
   
 Hypertensive/ Heart 
Failure 61 16.5 
    Diabetes/Heart diseases 60 16.3 
    Others 13 3.5 
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Table 2: Internal Consistency Cronbach’s α and Ceiling-Floor Effect for FACIT-F Version 4 (N=369) 




(%) Cronbach’s α 
Cronbach’s α 
Original Version 
  Mean SD     
Physical Well-Being 7 (0-28) 12.13 8.33 2.4% 3.8% .92 0.82a 
Social / Family Well-
Being 6
c (0-24) 19.75 3.82 17.6% .5% .73 0.69a 
Emotional Well-Being 5d (0-20) 12.14 5.35 8.4% 1.1% .84 0.74a 
Functional Well-Being 7 (0-28) 19.28 5.79 7% .5% .87 0.80 a 
FACT-G 25 items  25 (0-100) 63.3 17.71 0.3% - .92 0.89 a 
        
FACT-Fatigue 13 (0-52) 22.70 12.00 0.3% 0.5% .94 0.93b 
        
FACIT-F 38 (0-52) 86 29.15 - - .95 0.95b 
a Cella et al (1993), b Yellen et al, 1997 
c GS7 was removed from analyses 












Table 3: FACT-G and FACIT-Fatigue Scores According to the Patient Characteristics (Discriminant Validity): 
 FACIT-Fatigue FACT-G PWB SWB EWB FWB 
 M(SD) P M(SD) P M(SD) P M(SD) P M(SD) P M(SD) P 
Age  < 0.001  < 0.001  0.001  <0 .001  0.007  < 0.001 
18-30 (36) 25.3(12.9)  64.9(16.2)  13.4(7.9)  19.3(4.1)  11.9(5.4)  20.3(5.2)  
31-40 (84) 25.5(12.8)  69.3(17.5)  13.8(8.5)  20.9(3)  13.3(5.3)  21.2(5.0)  
41-50 (95) 25.3(12.9)  67.3(17.9)  13.3(8.5)  20.2(3.4)  13.1(5.5)  20.8(5.3)  
51-60 (76) 21.9(12)  60(16.1)  11.4(7.8)  19.6(4.1)  10.9(5.3)  18.1(5.3)  
˃ 60 (78) 16.1(12)  54.4(15.9)  9(7.8)  18.3(4.3)  11(4.9)  16.1(6.4)  
             
Cancer Site  < 0.001  <0 .001  < 0.001  0.102  <0 .001  < 0.001 
Breast (139) 26.1(13.3)  68.2(17.4)  14.1(8.2)  20.4(3.4)  13.2(5.2)  20.5(5.1)  
Colorectal (54) 20.9(12.6)  61.3(16.9)  10.7(8)  20(3)  11.2(5.1)  19.5(5.6)  
Stomach (18) 23.8(11.8)  61.7(18.5)  13.1(9)  18.6(6.1)  12.6(5.9)  17.5(6.1)  
Others (29) 27.1(11.8)  69(15)  13.9(7.9)  20(4)  14.5(4.7)  20.6(5.2)  
Lung (20) 15(11.1)  50(13.7)  7.6(7.5)  17.7(5.4)  9.4(5)  15.3(7.8)  
Gastrointestinal 
(19) 17.2(12.3)  49.9(17.4)  7.4(8.6)  19.1(3.9)  9.8(4.5)  13.6(5)  
Brain (19) 15 (10.9)  53.3(18.4)  7.7(8)  19.3(3.2)  8.6(6)  17.7(5.2)  
Lymphoma (20) 20.3(13.2)  63.9(15.2)  13.7(8.5)  18.7(4.6)  11.5(4.9)  20.1(5.3)  
Gynaecological 
(24) 20.6(10.1)  61(14.6)  10.4(6.7)  19.5(3.8)  12(5.1)  19.1(5.3)  
Urinary (27) 21.8(13.4)  65.1(18)  12.8(8.3)  19.8(3.5)  12.4(5.8)  20.1(6.4)  
             
Stage of Disease  0.25  0.004  0.17  0.11  0.07  < 0.001 
Ⅰ (34) 25.1(13.1)  69.6(18.9)  14.1(8.1)  21.3(3.2)  13.4(5.8)  20.8(5.5)  
Ⅱ (145) 23.6(11.9)  65.3(16.8)  12.8(8.4)  19.8(4.2)  12.7(5.2)  20(5.6)  
Ⅲ (107) 22.7(13.7)  62.9(16.4)  12(8.1)  19.6(3.3)  12(5)  19.4(5.5)  
Ⅳ (72) 19.9(13.7)  57(19.3)  10.4(8.5)  19.2(3.7)  10.8(5.5)  16.6(6.2)  
Unspecified (11) 21.5(13.8)  62.5(17)  10.3(8.2)  19.6(5.1)  10.8(7)  21.8(3.5)  
             
Comorbidities  <0 .001  <0 .001  <0 .001  .04  <0 .001  <0 .001 
No (193) 26.7(12.5)  68.6(16.8)  14.6(8.2)  22.9(4.5)  13.4(5.1)  20.6(5.6)  
Yes (176) 18.3(12.1)  57.5(16.8)  9.4(7.7)  21.9(4.5)  10.7(5.3)  17.9(5.6)  
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